Get the latest tech news
Cough syrup protects the brain from dementia in clinical trial first | This cough medicine is an unlikely new ally in slowing Parkinson's disease dementia
A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on other degenerative diseases.
A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on other degenerative diseases. In the study, 55 patients with Parkinson’s disease dementia (PDD) were given either a daily dose of Ambroxol or a placebo and had their memory, psychiatric symptoms and the brain-damage blood marker GFAP monitored. Ambroxol is at the center of another Parkinson's study, which isn't linked to dementia outcomes but a rare genetic condition known as Gaucher disease, and the Phase III two-year trial results are due out sometime in 2025.
Or read this on r/tech
